Characterization of Russian universal kits for real-time PCR: Application to molecular oncodiagnosis

Molecular Biology

Volumn 40, Issue 2, 2006, Pages 305-311

  Manzeniuk, O Yu ^a   Malakho, S G ^a   Pekhov, V M ^a   Kosorukova, I S ^b   Poltaraus, A B ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Acute promyelocytic leukemia; Chimeric PML RAR ; Fusion gene transcripts; Minimal residual disease; Q PCR Universal Ready Mix; Quantitative real time PCR; Translocation

Indexed keywords

EID: 33646513027     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893306020178     Document Type: Article

References (26)

1. Van Dongen J.J., Macintyre E.A., Gabert J.A., et al. 1999. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia. 13, 1901-1928.
2. Shin L.Y., Kuo M.Ch., Liang D.Ch., Huang C.F., et al. 2003. Internal tandem duplication and Asp 835. Mutations of the FMS-like tyrosine kinase3 (FLT3) gene in acute promyelocytic leukemia. Cancer. 98, 1206-1216.
3. Walker G.T., Little M.C., Nadeau J.G., et al. 1992. Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. Proc. Natl. Acad. Sci. USA. 89, 392-396.
4. Chantratita W., Pongtanapisit W., Piroj W., Srichunrasmi C., Seesuai S. 2004. Development and comparison of the real-time amplification based methods - NASBA-Beacon, RT-PCR taqman and RT-PCR hybridization probe assays - for the qualitative detection of sars coronavirus. Southeast Asian J. Trop. Med. Public. Health. 35, 623-629.
5. Romano J.W., Williams K.J., Shurtliff R.N., et al. 1997. NASBA technology: Isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol. Invest. 26, 15-28.
6. Heid C.A., Stevens J., Livak K. J., Williams P.M. 1996. Real time quantitative PCR. Genome Res. 6, 986-994.
7. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 88, 7276-7280.
8. Manzenyuk O.Yu., Moskalets O.V., Burdakova Yu.A., Suchkov S.V. 2002. Molecular typing in clinical diagnosis. Biopreparaty. 3, 16-18.
9. Gabert J., Beillard E., van der Velden V.H., et al. 2003. Standardization and quality control studies of "real time" quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: A Europe Against Cancer Program. Leukemia. 17, 2318-2357.
10. Cassinat B., Zassadowski F., Balitrand N., Barbey C., Rain J.D., Fenaux P., Degos L., Vidaud M., Chomienne C. 2000. Quantification of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia. 14, 324-328.
11. Boeckx N., Willemse M.J., Szczepanski T., van der Velden V.H.J., Langerak A.W., Vandekerckhove P., van Dongen J.J.M. 2002. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia. Leukemia. 16, 368-375.
12. Kondo M., Kudo K., Kimura H., et al. 2000. Real time quantitative reverse transcription polymerase chain reaction for the detection of AML-MTG8 fusion transcripts in t (8;21) - positive acute myelogenous leukemia. Leukemia Res. 24, 951-956.
13. Mitelman F. (Ed). 1991. ISCN: Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger.
14. Tobal K., Saunders M.J., Grey M.R., Yin J.A. 1995. Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukemia. Br. J. Haematol. 90, 615-618.
15. Lowenberg B., Downing J.R., Burnett A. 1999. Acute myeloid leukemia. N. Engl. J. Med. 341, 1051-1062.
16. Jurlander J., Caligiuri M.A., Ruutu T., et al. 1996. Persistence of the AML1/ETO fusion transcripts in patients treated with allogenic bone marrow transplantation for t(8; 21) leukemia. Blood. 88, 2183-2191.
17. Miamoto T., Nagafuji K., Akashi K., et al. 1996. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8; 21) acute myelogenous leukemia. Blood. 87, 4789-4796.
18. Cross N.C., Hughes T.P., Lin F., et al. 1993. Minimal residual disease after allogenic bone marrow transplantation for chronic myeloid leukemia in first chronic phase. Correlation with acute graft-versus-host disease and relapse. Br. J. Haematol. 84, 67-70.
19. Maniatis, T., Fritsch, E.F., Sambrook, J. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Lab. Press.
20. Sanger F., Niclen S., Coulson A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74, 5463-5467.
21. Pfaffl M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
22. Ramakers C., Ruijter J.M., Deprez R.H. and Moorman A.F. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339, 62-66.
23. Peirson S.N., Butler J.N., Foster R.G. 2003. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 31, e73.
24. Azeri B., Xing W., Sorge J.A., Hogrefe H.H. 2003. Amplification efficiency of thermostable DNA polymerases. Anal. Biochem. 321, 226-235.
25. Wolf P., Grage H., Hagberg O., Radstromom P. 2004. Impact of DNA polymerases and the buffer systems on quantitative real time PCR. J. Clin. Microbiol. 42, 408-411.
26. Swillens S., Goffard J.C., Marechal Y., de Kerchove d'Exaerde A., el Housni H. 2004. Instant evaluation of the absolute initial number of cDNA copies from a single real-time PCR curve. Nucleic Acids Res. 32, e56.